EpxCOPD minimizes preventable hospitalizations with remote patient monitoring
Epharmix developed a unique, evidence-based tool to help both patients and clinicians.
The M&A landscape for life sciences companies
McDermott Will & Emery partner Kristian Werling is co-chair of the firm’s robust Life Sciences practice. According to Krist, McDermott’s Life Sciences group has “all the tools in the toolkit to help life science entrepreneurs, growth-stage companies and large global companies achieve their patient-centered mission. Hearing patients, helping heal patients and everything in between.” About […]
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
The 10 Most Innovative Life Sciences Deals Of 2017
These transactions best exemplify the most significant trends in the life sciences and biotech space.
Technology Pioneer And The Convergence Of Supercomputing And The Life Sciences
Recently, MedCity News spoke with a pair of top executives at global supercomputing ...
Philadelphia is the place to be for innovation in the life sciences
Strengthening Partnerships, Expanding Opportunity
Wilson Sonsini tops Life Sciences Law Firm Index for 2nd straight year
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
Changes in Nurse Staffing Answer Clinician Demands
The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.
Which companies offer innovation for the 50+ market? You decide.
This week we invite readers to pick their favorites among the diverse companies driving innovation for the 50+ market.
Who is supporting healthcare innovation for the 50+ market? You decide.
Voting in the individual entrepreneurs and investors category will remain open until 8 p.m. on Feb. 23
Which entrepreneurs, ideas are adding innovation to healthcare delivery for the 50+ market? You decide.
This week we invite readers to pick their favorites among entrepreneurs and ideas that are driving innovation in the healthcare delivery category.
Who’s innovating in behavioral health and fitness for the 50+ market? You decide.
This week we invite readers to pick their favorites among companies innovating in the Behavioral Health/Physical Fitness category.
Consultants: Help Define What’s Next In Healthcare Benefits
Help shape the future of healthcare benefits by sharing your insights.
Which companies are innovating in healthcare delivery for the 50+ market? You decide.
This week we invite readers to pick their favorites among companies innovating in the Healthcare Delivery Company category.
Who’s innovating in smart wearables for the 50+ market? You decide
AARP and MedCity are looking for the most novel ideas, people and companies who are targeting the 50+ market. Vote for your favorites in the category of smart wearables.
Who’s innovating in medication management for the 50+ market? You decide
MedCity and AARP are collaborating to find the top people, ideas and companies that are innovating for the 50+ market. Here's our first installment of a reader survey that looks at how medication management is seeing disruption. Pick your favorite.
McKesson, Blue Cross top digital health’s most trusted corporate VCs
Part II in our research examining which corporate venture capitalists you can trust and rely on.